Association of the leukemia inhibitory factor gene mutation and the antiphospholipid antibodies in the peripheral blood of infertile women

Folia Microbiologica

Volumn 52, Issue 5, 2007, Pages 543-548

  Kralickova M ^a   Ulcova GALLOVA Z ^a   Sima R ^a   Vanecek T ^a   Sima P ^b   Krizan J ^b   Sucha R ^a   Uher, P ^a   Hes, O ^a   Novotny Z ^a   Rokyta, Z ^a   Vetvicka V ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, HUMAN; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; DNA SEQUENCE; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; GENETICS; HETERODUPLEX ANALYSIS; HUMAN; IMMUNOLOGY; METHODOLOGY; POINT MUTATION;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HETERODUPLEX ANALYSIS; HUMANS; INFERTILITY, FEMALE; LEUKEMIA INHIBITORY FACTOR; POINT MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 37749007702     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02932117     Document Type: Article

References (31)

1. AGHAJANOVA L.: Leukemia inhibitory factor and human embryo implantation. Ann.N. Y.Acad.Sci. 1034, 176-183 (2004).
2. ARON A.L., GHARAVI A.E., SHOENFELD Y.: Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Internat.Arch.Allergy Immunol. 106, 8-12 (1995).
3. BALASCH J., CREUS M., FABREGUES F., REVERTER J.C., CARMONA F., TASSIES D., FONT J., VANRELL J.A.: Antiphospholipid antibodies and human reproductive failure. Human Reprod. 11, 2310-2315 (1996).
4. BEER A.E., KWAK J.Y., RUIZ J.E.: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am.J.Reprod.Immunol. 35, 376-382 (1996).
5. BERANOVA M., OLIVEIRA L.M., BEDECARRATS G. Y., SCHIPANI E., VALLEJO M., AMMINI A.C., QUINTOS J.B., HALL J.E., MARTIN K.A., HAYES F.J., PITTELOUD N., KAISER U.B., CROWLEY W.F. Jr., SEMINARA S.B.: Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J.Clin. Endocrinol.Metab. 86, 1580-1588 (2001).
6. COULAM C.B., KAIDER B.D., KAIDER A.S., JANOWICZ P., ROUSSEV R.G.: Antiphospholipid antibodies associated with implantation failure after IVF/ET. J.Assist.Reprod.Genet. 14, 603-608 (1997).
7. COULAM C.B., ROUSSEV R.G.: Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologie implantation failure after in vitro fertilization and embryo transfer. J.Assist.Reprod.Genet. 20, 58-62 (2003).
8. ELDAR-GEVA T., WOOD C., LOLATGIS N., ROMBAUTS L., KOVACS G., FUSCALDO J., TROUNSON A.O.: Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Human Reprod. 14, 1461-1466 (1999).
9. GIESS R., TANASESCU I., STECK T., SENDTNER M.: Leukemia inhibitory factor gene mutations in infertile women. Mol.Human Reprod. 5, 581-586 (1999).
10. JOKHI P.P., KING A., SHARKEY A.M., SMITH S.K., LOKE Y.W.: Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J.Immunol. 153, 4427-4435 (1994).
11. KAIDER A.S., KAIDER B.D., JANOWICZ P.B., ROUSSEV R.G.: Immunodiagnostic evaluation in women with reproductive failure. Am. J.Reprod.Immunol. 42, 335-346 (1999).
12. KLENTZERIS L.D., BULMER J.N., WARREN M.A., MORRISON L., LI T.C., COOKE I.D.: Lymphoid tissue in the endometrium of women with unexplained infertility: morphometric and immunohistochemical aspects. Human Reprod. 9, 646-652 (1994).
13. KOWALIK A., VICHNIN M., LIU H.C., BRANCH W., BERKELEY A.S.: Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil.Steril. 68, 298-304 (1997).
14. KRÁLÍČKOVA M., ŠÍMA P., ROKYTA Z.: Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation - a delicate homeostatic equilibrium. Folia Microbiol. 50, 179-186 (2005).
15. ~KRÁLÍČKOVA M., ŠÍMA R., VANĚČEK T., ŠÍMA P., ROKYTA Z., ULČOVÁ-GALLOVÁ Z., SUCHÁ R., UHER P., HES O.: Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients. Eur.J.Obstet.Gynecol. Reprod.Biol. 127, 231-235 (2006).
16. KUBRYCHT J., MALÍKOVÁ P., HUAN N.H., FIŠEROVÁ A., BEZOUŠKA K., KRUŽÍK P., STAJNER K., MORAVEC V., POSPIŠIL M.: Peripheral membrane molecules of leukocytes and NK cytotoxicity. Folia Microbiol. 38, 421-431 (1993).
17. + cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am.J.Reprod.Immu nol. 34, 93-99 (1995).
18. + CD56 DIM NK cells is increased in IVF patients with idiopathic infertility. J.Reprod.Immunol. 60, 71-84 (2003).
19. MATSUBAYASHI H., HOSAKA T., SUGIYAMA Y., SUZUKI T., ARAI T., KONDO A., SUGI T., IZUMI S., MAKINO T.: Increased natural killer-cell activity is associated with infertile women. Am.J.Reprod.Immunol. 46, 318-322 (2001).
20. MCINTYRE J.A.: Antiphospholipid antibodies in implantation failures. Am.J.Reprod.Immunol. 49, 221-229 (2003).
21. - cells in total natural killer cells as an indication of fertility and infertility. Fertil.Steril. 80 (Suppl. 2), 691-697 (2003).
22. NAKAMURA Y., FUJINO Y., OZAKI K., UEDA K., OZAKI A., ITOH F., OGITA S.: Suppression of natural killer cell activity and interleukin-2 concentration of serum obtained from in vitro fertilization-embryo transfer patients. Am.J.Reprod.Immunol. 40, 9-12 (1998).
23. NTRIVALAS E.I., KWAK-KIM J.Y., GILMAN-SACHS A., CHUNG-BANG H., NG S.C., BEAMAN K.D., MANTOUVALOS H.P., BEER A.E.: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown etiology. Human Reprod. 16, 855-861 (2001).
24. ROUSSEV R.G., KAIDER B.D., PRICE D.E., COULAM C.B.: Laboratory evaluation of women experiencing reproductive failure. Am.J.Reprod.Immunol. 35, 415-420 (1996).
25. bright natural killer cells in the human early pregnancy decidua. Internat.Immunol. 5, 559-563 (1993).
26. SCHOFIELD G., KIMBER S.J.: Leukocyte subpopulations in the uteri of leukemia inhibitory factor knockout mice during early pregnancy. Biol.Reprod. 72, 872-878 (2005).
27. SHER G., FISCH J.D., MAASSARANI G., MATZNER W., CHING W., CHONG P.: Antibodies to phosphatidylethanolamine and phosphatidylserine are associated with increased natural killer cell activity in non-male factor infertility patients. Human Reprod. 15, 1932-1936 (2000).
28. STECK T., GIESS R., SUETTERLIN M.W., BOLLAND M., WIEST S., POEHLS U.G., DIETL J.: Leukemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur.J.Obstet. Gynecol.Reprod.Biol. 112, 69-73 (2004).
29. ULČOVÁ-GALLOVÁ Z., KRAUZ V., BOUSE V., NOVOTNÝ Z., ROKYTA Z., FIALOVÁ P., VONDRÁČEK J.: Correlation between peritoneal fluid and serum antiphospholipid antibodies in women with primary infertility. Internat.J.Fertil.Womens Med. 43, 267-272 (1998).
30. ULČOVÁ-GALLOVÁ Z., NOVOTNÝ Z., BOUSE V., ŠVÁBEK L., ROKYTA Z., HRADECKÝ L., KNAIZL Z., FIALOVÁ P.: Immunologic factors in the serum and peritoneal fluid in women after laparoscopy. Nonspecific factors. Česká Gynekol. 61, 23-27 (1996).
31. ULČOVÁ-GALLOVÁ Z., BOUSE V., ŠVÁBEK L., TUREK J., ROKYTA Z.: Endometriosis in reproductive immunology. Am.J.Reprod.Immunol. 47, 269-274 (2002).